These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 9309373

  • 1. Fleroxacin 400 mg once daily versus ofloxacin 400 mg twice daily in skin and soft tissue infections.
    Drehobl M, Koenig L, Barker M, St Clair P, Maladorno D.
    Chemotherapy; 1997; 43(5):378-84. PubMed ID: 9309373
    [Abstract] [Full Text] [Related]

  • 2. Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study.
    Tarshis GA, Miskin BM, Jones TM, Champlin J, Wingert KJ, Breen JD, Brown MJ.
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2358-62. PubMed ID: 11451697
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.
    Tassler H.
    Am J Med; 1993 Mar 22; 94(3A):159S-165S. PubMed ID: 8452174
    [Abstract] [Full Text] [Related]

  • 4. Open trial of oral fleroxacin versus amoxicillin/clavulanate in the treatment of infections of skin and soft tissue.
    Powers RD.
    Am J Med; 1993 Mar 22; 94(3A):155S-158S. PubMed ID: 8452173
    [Abstract] [Full Text] [Related]

  • 5. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
    Schrenzel J, Harbarth S, Schockmel G, Genné D, Bregenzer T, Flueckiger U, Petignat C, Jacobs F, Francioli P, Zimmerli W, Lew DP, Swiss Staphylococcal Study Group.
    Clin Infect Dis; 2004 Nov 01; 39(9):1285-92. PubMed ID: 15494904
    [Abstract] [Full Text] [Related]

  • 6. Comparison of oral fleroxacin with oral amoxicillin/clavulanate for treatment of skin and soft tissue infections.
    Smith JW, Nichols RL.
    Am J Med; 1993 Mar 22; 94(3A):150S-154S. PubMed ID: 8452172
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ofloxacin treatment of difficult infections of the skin and skin structure.
    Gentry LO, Rodriguez-Gomez G.
    Cutis; 1993 Jan 22; 51(1):55-8. PubMed ID: 8419113
    [Abstract] [Full Text] [Related]

  • 11. Fleroxacin versus ofloxacin in patients with complicated urinary tract infection: a controlled clinical study.
    Naber KG, Sigl G.
    Am J Med; 1993 Mar 22; 94(3A):114S-117S. PubMed ID: 8452166
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Systemic antimicrobial therapy for skin and skin structure infections: comparison of fleroxacin and ceftazidime.
    Parish LC, Jungkind DL.
    Am J Med; 1993 Mar 22; 94(3A):166S-173S. PubMed ID: 8452175
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A pilot study of oral fleroxacin given once daily in patients with bone and joint infections.
    Putz PA.
    Am J Med; 1993 Mar 22; 94(3A):177S-181S. PubMed ID: 8452177
    [Abstract] [Full Text] [Related]

  • 17. Treatment of posttraumatic osteitis with intravenous ofloxacin.
    Seibold R, Betz A.
    Clin Ther; 1991 Mar 22; 13(4):457-9. PubMed ID: 1933996
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trial.
    Torum B, Block SL, Avila H, Montiel F, Oliva A, Quintanilla W, Duncanson F, Cantrell HF, Riefler J, Katz E, Lombardy E.
    Clin Ther; 2004 Jul 22; 26(7):1046-54. PubMed ID: 15336469
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections.
    Childs SJ.
    Am J Med; 1993 Mar 22; 94(3A):105S-107S. PubMed ID: 8452164
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.